logo
Book a meeting
Eradivir

Eradivir

Biotechnology, 1690 Air Force Pentagon, West Lafayette, Indiana, 20330, United States, 1-10 Employees

eradivir.com

  • LinkedIn

phone no Phone Number: +17*********

Who is ERADIVIR

Our overarching goal is to focus the power of a patients immune system to kill both viruses and virus-infected cells, thereby eliminating a viral infection without causing damage to any u...

Read More

lock icon Get Full Access
map
  • 1690 Air Force Pentagon, West Lafayette, Indiana, 20330, United States Headquarters: 1690 Air Force Pentagon, West Lafayette, Indiana, 20330, United States
  • 2020 Date Founded: 2020
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ERADIVIR

Eradivir Org Chart and Mapping

Employees
Chase Nielsen

Chase Nielsen

Investor

Ian Alford

Ian Alford

Research Assistant

See Full Org Chart arrow
email-formate-icon
View Email Formats for Eradivir
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Eradivir

Answer: Eradivir's headquarters are located at 1690 Air Force Pentagon, West Lafayette, Indiana, 20330, United States

Answer: Eradivir's phone number is +17*********

Answer: Eradivir's official website is https://eradivir.com

Answer: Eradivir's revenue is $1 Billion and Over

Answer: Eradivir's SIC: 2836

Answer: Eradivir's NAICS: 541714

Answer: Eradivir has 1-10 employees

Answer: Eradivir is in Biotechnology

Answer: Eradivir contact info: Phone number: +17********* Website: https://eradivir.com

Answer: Our overarching goal is to focus the power of a patients immune system to kill both viruses and virus-infected cells, thereby eliminating a viral infection without causing damage to any uninfected cells. To achieve this, we employ a novel bispecific immunotherapy that eradicates a virus by tethering a patients cytotoxic immune cells specifically to the pathogenic virus or virus-infected cell, i.e. facilitating the rapid and selective destruction of the virus by the patients immune system. With a toolkit of these small bispecific molecules, we will be able to treat and potentially cure influenza, multiple coronaviruses, hepatitis B, HIV, and even cancers without damaging a patients healthy cells.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access